HEMISPHERX BIOPHARMA INC
10-Q, EX-27, 2000-08-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: HEMISPHERX BIOPHARMA INC, 10-Q, 2000-08-14
Next: FIRST DEFIANCE FINANCIAL CORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                           <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-END>                  JUN-30-2000
<CASH>                          8,249,618
<SECURITIES>                    2,236,769
<RECEIVABLES>                     114,450
<ALLOWANCES>                      (26,150)
<INVENTORY>                             0
<CURRENT-ASSETS>               10,942,327
<PP&E>                          1,222,540
<DEPRECIATION>                   (832,439)
<TOTAL-ASSETS>                 15,277,105
<CURRENT-LIABILITIES>           1,245,024
<BONDS>                                 0
                   0
                             0
<COMMON>                           29,812
<OTHER-SE>                     14,002,269
<TOTAL-LIABILITY-AND-EQUITY>   14,032,081
<SALES>                                 0
<TOTAL-REVENUES>                  809,225
<CGS>                                   0
<TOTAL-COSTS>                   4,841,071
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                         0
<INCOME-TAX>                            0
<INCOME-CONTINUING>            (4,031,846)
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                   (4,031,846)
<EPS-BASIC>                        (.14)
<EPS-DILUTED>                        (.14)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission